Delivery Order SPE2DE21D0005-SPE2D625F5A8B

Award Date 4/28/25
Potential Completion Date 5/1/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. Organogenesis, a for-profit manufacturer, has an established track record of supplying specialized medical supplies, including wound care and tissue regeneration solutions, to the...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
This federal contract award, valued at $3,719.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for the medical product APLIGRAF, a skin substitute. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for surgical implants, a $30 million...
This is a federal contract award from the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The award, valued at $1,239.95, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle held by Organogenesis with the DLA, valued at $49.5 million, for wound care dressings and medical supplies. This IDC was awarded as a total small...
This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order, with a Ceiling Value of $1,239.95, and a Fixed Price with Economic Price Adjustment pricing type. The contract has an Ultimate Completion Date of April 17, 2025. Organogenesis Inc. is a for-profit...
This federal contract award is to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, valued at $2,479.90, is a delivery order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The award is for the supply of the APLIGRAF advanced wound care product, a specialized skin substitute and tissue regeneration solution used in medical treatments. The contract does not utilize any set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit medical device manufacturer based in Canton, Massachusetts. The contract, valued at $1,239.95, is for the provision of APLIGRAF, a skin substitute product used for advanced wound care. The contract does not have a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis has established itself as a key...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order (SPE2DE21D0005|SPE2D625F228P) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is for the delivery of the advanced wound care product APLIGRAF. The order is a Fixed Price with Economic Price Adjustment contract with a completion date of November 1, 2024. Organogenesis, headquartered in Canton, Massachusetts, is a key supplier of medical products to federal...
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
This federal contract award, with ID SPE2DE21D0005|SPE2D625F31DY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products headquartered in Canton, Massachusetts. The $1,239.95 delivery order is for the supply of APLIGRAF, a skin substitute product, and does not utilize any set-aside designation. Organogenesis is an established vendor for the DLA and the Department of Veterans Affairs (VA), providing...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F5A8B
    Delivery Order

This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products based in Canton, Massachusetts. The contract is a delivery order for the APLIGRAF skin substitute product, with a period of performance through May 1, 2025. This award is not associated with a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis maintains several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued up to $49.5 million, for the provision of advanced wound care, surgical biologics, and tissue regeneration solutions. These contract vehicles enable Organogenesis to supply a range of specialized medical products to support treatments across military and veteran healthcare programs.

Generated 7/28/25, 11:04 AM